Cargando…

A phase II trial of dose-reduced nab-paclitaxel for patients with previously treated, advanced or recurrent gastric cancer (OGSG 1302)

BACKGROUND: For unresectable or recurrent advanced gastric adenocarcinoma (AGC), tri-weekly administration of nanoparticle albumin-bound paclitaxel (nab-PTX) at 260 mg/m(2) achieved a response rate of 27.8% in a phase II trial in Japan. However, frequent neutropenia and peripheral neuropathy limit i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tamura, Shigeyuki, Taniguchi, Hirokazu, Nishikawa, Kazuhiro, Imamura, Hiroshi, Fujita, Junya, Takeno, Atsushi, Matsuyama, Jin, Kimura, Yutaka, Kawada, Junji, Hirao, Motohiro, Hirota, Masashi, Fujitani, Kazumasa, Kurokawa, Yukinori, Sakai, Daisuke, Kawakami, Hisato, Shimokawa, Toshio, Satoh, Taroh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Singapore 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7677284/ https://www.ncbi.nlm.nih.gov/pubmed/32926227 http://dx.doi.org/10.1007/s10147-020-01768-w

Ejemplares similares

Effects of an oral elemental nutritional supplement in gastric cancer patients with adjuvant S‐1 chemotherapy after gastrectomy: A multicenter, open‐label, single‐arm, prospective phase II study (OGSG1108)
por: Imamura, Hiroshi, et al.
Publicado: (2021)

Randomized, Open‐Label Phase II Study Comparing Capecitabine‐Cisplatin Every 3 Weeks with S‐1‐Cisplatin Every 5 Weeks in Chemotherapy‐Naïve Patients with HER2‐Negative Advanced Gastric Cancer: OGSG1105, HERBIS‐4A Trial
por: Kawakami, Hisato, et al.
Publicado: (2018)

Neoadjuvant docetaxel, oxaliplatin and S-1 therapy for the patients with large type 3 or type 4 gastric cancer (OGSG1902): protocol of a multi-center, phase II study
por: Endo, Shunji, et al.
Publicado: (2022)

Protocol of OGSG 1901: a phase II trial of ramucirumab plus irinotecan for patients with early relapsed gastric cancer during or after adjuvant docetaxel plus S − 1 therapy
por: Yamaguchi, Toshifumi, et al.
Publicado: (2022)

Three-Year Outcomes of a Phase II Study of Perioperative Capecitabine Plus Oxaliplatin Therapy for Clinical SS/SE N1-3 M0 Gastric Cancer (OGSG 1601)
por: Matsuyama, Jin, et al.
Publicado: (2022)

Histology Classification Highlights Differences in Efficacy of S-1 versus Capecitabine, in Combination with Cisplatin, for HER2-Negative Unresectable Advanced or Recurrent Gastric Cancer with Measurable Disease
por: Kawakami, Hisato, et al.
Publicado: (2022)

First-line single-agent panitumumab in frail elderly patients with wild-type RAS unresectable colorectal cancer: a phase II study protocol OGSG 1602
por: Terazawa, Tetsuji, et al.
Publicado: (2019)

The Phase II Study of Panitumumab in Chemotherapy-Naïve Frail or Elderly Patients with RAS Wild-type Colorectal Cancer: OGSG 1602 Final Results
por: Terazawa, Tetsuji, et al.
Publicado: (2022)

Long‐term results of a randomized controlled trial comparing neoadjuvant Adriamycin, cisplatin, and 5‐fluorouracil vs docetaxel, cisplatin, and 5‐fluorouracil followed by surgery for esophageal cancer (OGSG1003)
por: Sugimura, Keijiro, et al.
Publicado: (2020)

Multicentre biomarker cohort study on the efficacy of nivolumab treatment for gastric cancer
por: Hagi, Takaomi, et al.
Publicado: (2020)

Comparison of 5‐year postoperative outcomes after Billroth I and Roux‐en‐Y reconstruction following distal gastrectomy for gastric cancer: Results from a multi‐institutional randomized controlled trial
por: Kimura, Yutaka, et al.
Publicado: (2020)

Real-world effectiveness of third- or later-line treatment in Japanese patients with HER2-positive, unresectable, recurrent or metastatic gastric cancer: a retrospective observational study
por: Sakai, Daisuke, et al.
Publicado: (2022)

Ratio of βv at scrapers SHV1302 and SLV2105
por: Koziol, H, et al.
Publicado: (1983)

1302. Impact of Insurance Coverage on the Route of Antibiotic Treatment for Forefoot Osteomyelitis
por: Ritter, Austin, et al.
Publicado: (2023)

Large-scale linkage analysis of 1302 affected relative pairs with rheumatoid arthritis
por: Hamshere, Marian L, et al.
Publicado: (2007)

Runs 1302 and 1303, 3.5 GeV/c Ring 2
por: Baird, S
Publicado: (1983)

1302. HIV Testing in Adults Presenting with Central Nervous System (CNS) Infections
por: Ma, Bert, et al.
Publicado: (2019)

Survival impact of microsatellite instability in stage II gastric cancer patients who received S-1 adjuvant monotherapy after curative resection
por: Sato, Chihiro, et al.
Publicado: (2023)

P13.02 Role of Management Checklist in the Prevention and Control of NCP in Oncology Ward
por: Li, L., et al.
Publicado: (2021)

Long‐term effects of an oral elemental nutritional supplement on post‐gastrectomy body weight loss in gastric cancer patients (KSES002)
por: Kimura, Yutaka, et al.
Publicado: (2019)

Conventional or Drug-Eluting Beads? Randomized Controlled Study of Chemoembolization for Hepatocellular Carcinoma: JIVROSG-1302
por: Ikeda, Masafumi, et al.
Publicado: (2022)

Risk factors for posterior capsule rupture in mature cataract surgery: A study of 1302 cases
por: Keles, Ali, et al.
Publicado: (2023)

Phase 2 trial of neoadjuvant docetaxel, oxaliplatin, and S‐1 for clinical stage III gastric or esophagogastric junction adenocarcinoma
por: Kurokawa, Yukinori, et al.
Publicado: (2022)

Antifungal Activity and Plant Growth-Promoting Properties of Bacillus mojovensis B1302 against Rhizoctonia Cerealis
por: Yi, Yanjie, et al.
Publicado: (2022)

Increases in Cellular Immune Responses Due to Positive Effect of CVC1302-Induced Lysosomal Escape in Mice
por: Yu, Xiaoming, et al.
Publicado: (2023)

Shortage of Nab-paclitaxel in Japan and around the World: Issues in Global Information Sharing
por: Oura, Mitsuaki, et al.
Publicado: (2023)

Draft Genomic Sequences of Bacillus amyloliquefaciens CBMAI 1301 and Bacillus subtilis CBMAI 1302, Strains with Potential for the Biocontrol of Phytopathogens
por: Kitano, Isabella Takahashi, et al.
Publicado: (2021)

Pattern-Recognition Receptor Agonist-Containing Immunopotentiator CVC1302 Boosts High-Affinity Long-Lasting Humoral Immunity
por: Du, Luping, et al.
Publicado: (2021)

P1302: INTEGRATION OF ROUTINE RNA AND WHOLE-EXOME SEQUENCING AND FLOW CYTOMETRY IMPROVES THE DIAGNOSTIC WORKUP OF PEDIATRIC LYMPHOMAS
por: Westera, L., et al.
Publicado: (2022)

The potential clinical utility of cell-free DNA for gastric cancer patients treated with nivolumab monotherapy
por: Inagaki, Chiaki, et al.
Publicado: (2023)

Utility of monthly minodronate for osteoporosis after gastrectomy: Prospective multicenter randomized controlled trials
por: Hirota, Masashi, et al.
Publicado: (2021)

Peritoneal metastasis as a predictive factor for nab-paclitaxel in patients with pretreated advanced gastric cancer: an exploratory analysis of the phase III ABSOLUTE trial
por: Takashima, Atsuo, et al.
Publicado: (2018)

Analysis of xanthyletin and secondary metabolites from Pseudomonas stutzeri ST1302 and Klebsiella pneumoniae ST2501 against Pythium insidiosum
por: Wittayapipath, Kittiya, et al.
Publicado: (2019)

P16-07. HLA-B1302 is associated with viral control in clade CRF01_AE HIV-1 infection in Thailand
por: Hempel, U, et al.
Publicado: (2009)

Human leukocyte antigen class II DRB1*1302 allele protects against cervical cancer: At which step of multistage carcinogenesis?
por: Matsumoto, Koji, et al.
Publicado: (2015)

1302. Antibiotic Prescribing Knowledge: A Brief Survey of Providers and Staff at an Ambulatory Cancer Center During Antibiotic Awareness Week 2017
por: Stohs, Erica, et al.
Publicado: (2018)

Big Bang scientist nabbed
Publicado: (2009)

New Ways To Nab Nitrogen
por: Ritter, Stephen K.
Publicado: (2017)

OA13.02. Utilizing mind-body practices in public schools: teaching self-regulation skills and fostering resilience in our next generation
por: Sprengel, M, et al.
Publicado: (2012)

Nab: Measurement Principles, Apparatus and Uncertainties
por: Pocanic, Dinko, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_vi3ps2ohdkmg8bq0h06dcg44qr